© 2020 MJH Life Sciences and Cancer Network. All rights reserved.
Author | Eileen Parkes, MD, PhD
Articles
Eileen Parkes on Why Cancer Researchers Are Excited About STING Agonists
August 15, 2018
ByEileen Parkes, MD, PhDONCOLOGY recently interviewed Dr. Eileen Parkes, whose laboratory studies the STING pathway, to find out why researchers are excited about targeting this pathway as a potential cancer therapy.
My Signature Scent
March 15, 2018
ByEileen Parkes, MD, PhDLate last year, ONCOLOGY hosted a writing contest on CancerNetwork.com, in which we asked our readers to share their personal experiences with delivering bad news. The essay by Dr. Eileen Parkes from Queen’s University Belfast, United Kingdom, was selected as the first place winner.